FierceBiotech  5 hrs ago  Comment 
OrphoMed gained a $39 million early funding boost from a Japanese big pharma and a host of VCs as it looks to push on with work on its leading med for forms of irritable bowel syndrome that it hopes can have a better safety profile than those meds...
FierceBiotech  May 22  Comment 
Perennial biotech investor and backer Takeda has signed its latest collaboration with Nektar Therapeutics that will see the pair work on combo cancer approaches with NKTR-214, a CD122-biased agonist, as well as five Takeda oncology compounds.
FiercePharma  May 12  Comment 
Wockhardt reported a widened fourth-quarter loss amid growing FDA issues, Takeda penned a T-cell platform deal with upstart GammaDelta and Mitsubishi Tanabe’s Radicava became the first ALS drug approved in the U.S. in 22 years.
GenEng News  May 9  Comment 
Takeda has negotiated an exclusive right to acquire GammaDelta Therapeutics as part of a strategic collaboration to progress the U.K. startup’s human tissue-derived gamma delta (γδ) T-cell platform for the development of T-cell immunotherapies...
FierceBiotech  May 9  Comment 
In what is becoming an increasingly common pattern, Takeda has signed up to a collaboration with a small and very young biotech with an option to buy the company down the road.


No more s***. All posts of this qaultiy from now on

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki